Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 7.26
(0.55%)
CNY 7.26
(0.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.82 Billion CNY | 14.42% |
| 2022 | 1.59 Billion CNY | 11.2% |
| 2021 | 1.43 Billion CNY | 42.12% |
| 2020 | 1 Billion CNY | 1.35% |
| 2019 | 993.39 Million CNY | 16.02% |
| 2018 | 856.24 Million CNY | 20.05% |
| 2017 | 713.23 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.83 Billion CNY | 1.71% |
| 2024 Q2 | 1.8 Billion CNY | -0.63% |
| 2024 Q1 | 1.81 Billion CNY | -0.07% |
| 2023 FY | 1.82 Billion CNY | 14.42% |
| 2023 Q2 | 1.61 Billion CNY | 2.13% |
| 2023 Q1 | 1.57 Billion CNY | -0.89% |
| 2023 Q4 | 1.82 Billion CNY | 5.52% |
| 2023 Q3 | 1.72 Billion CNY | 7.12% |
| 2022 Q3 | 1.51 Billion CNY | 3.83% |
| 2022 Q2 | 1.46 Billion CNY | -0.54% |
| 2022 Q1 | 1.47 Billion CNY | 2.78% |
| 2022 FY | 1.59 Billion CNY | 11.2% |
| 2022 Q4 | 1.59 Billion CNY | 4.77% |
| 2021 FY | 1.43 Billion CNY | 42.12% |
| 2021 Q1 | 1.08 Billion CNY | 7.31% |
| 2021 Q4 | 1.43 Billion CNY | 2.17% |
| 2021 Q3 | 1.4 Billion CNY | 3.37% |
| 2021 Q2 | 1.35 Billion CNY | 25.39% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q3 | 962.76 Million CNY | 3.67% |
| 2020 Q2 | 928.68 Million CNY | 0.0% |
| 2020 Q4 | 1 Billion CNY | 4.58% |
| 2020 FY | 1 Billion CNY | 1.35% |
| 2019 FY | 993.39 Million CNY | 16.02% |
| 2019 Q4 | 993.39 Million CNY | 0.0% |
| 2018 FY | 856.24 Million CNY | 20.05% |
| 2017 FY | 713.23 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 14.3 Billion CNY | 87.278% |
| Joinn Laboratories(China)Co.,Ltd. | 10.02 Billion CNY | 81.844% |
| WuXi AppTec Co., Ltd. | 74.26 Billion CNY | 97.549% |
| Autobio Diagnostics Co., Ltd. | 11.55 Billion CNY | 84.243% |
| Thalys Medical Technology Group Inc. | 3.34 Billion CNY | 45.521% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 11.76 Billion CNY | 84.529% |